全文获取类型
收费全文 | 223978篇 |
免费 | 21083篇 |
国内免费 | 11050篇 |
专业分类
耳鼻咽喉 | 2620篇 |
儿科学 | 6412篇 |
妇产科学 | 2226篇 |
基础医学 | 36819篇 |
口腔科学 | 6657篇 |
临床医学 | 17771篇 |
内科学 | 31519篇 |
皮肤病学 | 5010篇 |
神经病学 | 12190篇 |
特种医学 | 5132篇 |
外国民族医学 | 125篇 |
外科学 | 36379篇 |
综合类 | 33256篇 |
现状与发展 | 56篇 |
一般理论 | 4篇 |
预防医学 | 5278篇 |
眼科学 | 4743篇 |
药学 | 15020篇 |
39篇 | |
中国医学 | 5674篇 |
肿瘤学 | 29181篇 |
出版年
2024年 | 360篇 |
2023年 | 3001篇 |
2022年 | 4871篇 |
2021年 | 7880篇 |
2020年 | 7284篇 |
2019年 | 7146篇 |
2018年 | 7377篇 |
2017年 | 7759篇 |
2016年 | 8173篇 |
2015年 | 9124篇 |
2014年 | 13568篇 |
2013年 | 15028篇 |
2012年 | 12535篇 |
2011年 | 14322篇 |
2010年 | 12189篇 |
2009年 | 11806篇 |
2008年 | 12233篇 |
2007年 | 12545篇 |
2006年 | 11685篇 |
2005年 | 10621篇 |
2004年 | 9134篇 |
2003年 | 7768篇 |
2002年 | 6326篇 |
2001年 | 5380篇 |
2000年 | 4500篇 |
1999年 | 3899篇 |
1998年 | 3680篇 |
1997年 | 3334篇 |
1996年 | 3016篇 |
1995年 | 2599篇 |
1994年 | 2425篇 |
1993年 | 1874篇 |
1992年 | 1688篇 |
1991年 | 1491篇 |
1990年 | 1129篇 |
1989年 | 1064篇 |
1988年 | 1000篇 |
1987年 | 775篇 |
1986年 | 707篇 |
1985年 | 920篇 |
1984年 | 799篇 |
1983年 | 541篇 |
1982年 | 608篇 |
1981年 | 483篇 |
1980年 | 419篇 |
1979年 | 301篇 |
1978年 | 223篇 |
1977年 | 177篇 |
1976年 | 135篇 |
1975年 | 50篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
81.
82.
周天保 《中华移植杂志(电子版)》2019,13(3):252-254
目前,国内外肝移植学界对肝移植术后急性排斥反应(AR)的机制阐释为T细胞介导的细胞免疫应答,但为获得长期生存仍需长期乃至终身服用免疫抑制剂。即使如此,临床上AR仍时有发生,并导致相当一部分受者移植肝功能丧失,更重要的是受者术后还受到感染、肿瘤和其他一系列不良反应及沉重经济负担的影响。因此,为肝移植AR机制提出新的理论解释,更全面深入阐明肝移植免疫排斥反应的内在机制,进而依据新的机制研制出新型免疫抑制剂已势在必行。本文就B细胞介导的体液免疫应答在肝移植AR中的作用作一综述。 相似文献
83.
84.
《Molecular therapy》2022,30(6):2186-2198
- Download : Download high-res image (179KB)
- Download : Download full-size image
85.
86.
《Vaccine》2019,37(31):4302-4309
Influenza A virus (IAV) vaccines in pigs generally provide homosubtypic protection but fail to prevent heterologous infections. In this pilot study, the efficacy of an intradermal pDNA vaccine composed of conserved SLA class I and class II T cell epitopes (EPITOPE) against a homosubtypic challenge was compared to an intramuscular commercial inactivated whole virus vaccine (INACT) and a heterologous prime boost approach using both vaccines. Thirty-nine IAV-free, 3-week-old pigs were randomly assigned to one of five groups including NEG-CONTROL (unvaccinated, sham-challenged), INACT-INACT-IAV (vaccinated with FluSure XP® at 4 and 7 weeks, pH1N1 challenged), EPITOPE-INACT-IAV (vaccinated with PigMatrix EDV at 4 and FluSure XP® at 7 weeks, pH1N1 challenged), EPITOPE-EPITOPE-IAV (vaccinated with PigMatrix EDV at 4 and 7 weeks, pH1N1 challenged), and a POS-CONTROL group (unvaccinated, pH1N1 challenged). The challenge was done at 9 weeks of age and pigs were necropsied at day post challenge (dpc) 5. At the time of challenge, all INACT-INACT-IAV pigs, and by dpc 5 all EPITOPE-INACT-IAV pigs were IAV seropositive. IFNγ secreting cells, recognizing vaccine epitope-specific peptides and pH1N1 challenge virus were highest in the EPITOPE-INACT-IAV pigs at challenge. Macroscopic lung lesion scores were reduced in all EPITOPE-INACT-IAV pigs while INACT-INACT-IAV pigs exhibited a bimodal distribution of low and high scores akin to naïve challenged animals. No IAV antigen in lung tissues was detected at necropsy in the EPITOPE-INACT-IAV group, which was similar to naïve unchallenged pigs and different from all other challenged groups. Results suggest that the heterologous prime boost approach using an epitope-driven DNA vaccine followed by an inactivated vaccine was effective against a homosubtypic challenge, and further exploration of this vaccine approach as a practical control measure against heterosubtypic IAV infections is warranted. 相似文献
87.
《Immunity》2022,55(7):1316-1326.e4
- Download : Download high-res image (134KB)
- Download : Download full-size image
88.
器官移植术是20世纪出现的针对器官功能衰竭的最有效治疗方法,每年拯救全球超过12万例患者。但供器官短缺的现状,与器官移植技术和辅助药物的发展不匹配,制约了器官移植事业的发展。我国自2015年起已成为全球器官捐献和移植大国之一,2017年公民逝世后器官捐献数量超过5 000例,占全球捐献总量的15%以上。黄洁夫教授总结的器官捐献与移植"中国模式"得到了世界卫生组织、国际移植界的高度重视和充分肯定。本文通过整理全球及各国的器官捐献与移植数据,剖析全球现状与发展趋势,进一步探索我国公民器官捐献的影响因素并提出针对性的应对策略,以期实现我国器官捐献和移植的"自给自足"。 相似文献
89.
《Annals of hepatology》2019,18(2):397-401
We report the case of a 53-year-old-man who developed human T-cell leukemia virus type-1-associated myelopathy (HAM) after ABO-incompatible liver transplantation for alcoholic liver cirrhosis. The living donor was seropositive for human T-cell leukemia virus type-1 (HTLV-1) and the recipient was seronegative for HTLV-1 before transplantation. After transplantation, the recipient developed steroid-resistant acute cellular rejection, which was successfully treated using anti-thymocyte globulin, and he was eventually discharged. He underwent spinal surgery twice after the transplantation for the treatment of cervical spondylosis that had been present for a period of 9 months before the transplantation. The surgery improved his gait impairment temporarily. However, his gait impairment progressed, and magnetic resonance imaging revealed multiple sites of myelopathy. He was diagnosed with HAM 16 months after the transplantation. Pulse steroid therapy (1000 mg) was administered over a period of 3 days, and his limb paresis improved. Presently, steroid therapy is being continued, with a plan to eventually taper the dose, and he is being carefully followed up at our institution. Our case suggests that liver transplantation involving an HTLV-1-positive living donor carries the risk of virus transmission and short-term development of HAM after transplantation. 相似文献
90.
肺癌是目前全球发病率和死亡率均居前列的恶性肿瘤,其中肺鳞癌经手术、放化疗等综合治疗后,其疗效仍不满意。随着分子靶向治疗在肺腺癌中取得了令人瞩目的成果,而肺鳞癌患者中EGFR基因突变及ALK融合基因少见,急需探索新的靶点指导肺鳞癌患者的临床治疗。研究表明,FGFR家族(FGFR1-4)是肺鳞癌中突变频率较高的基因,FGFR基因的激活突变和扩增与肺鳞癌的发生和发展密切相关,同时许多小分子 FGFR 抑制剂在临床应用中已经取得较好的治疗效果。目前,许多FGFR抑制剂治疗肺鳞癌的临床试验也正在进行研究,针对FGFR靶点的基因治疗可为肺鳞癌的治疗提供一种新的策略。本文就FGFR在肺鳞癌的靶向治疗中的最新研究进展进行综述。 相似文献